HGYN.US Hong Yuan Holding Group
- Market cap
- USD 2.24M
- P/E
- -
- P/B
- 0.93x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is HGYN.US undervalued?
Graham numberThe Graham number of Hong Yuan Holding Group cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hong Yuan Holding Group fundamental analysis
No fundamental analysis for Hong Yuan Holding Group yet.
Hong Yuan Holding Group stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hong Yuan Holding Group
Hong Yuan Holding Group does not have significant operations. previously, the company was engaged in the development and commercialization of bio-based resins. The company was formerly known as Cereplast, Inc. and changed its name to Hong Yuan Holding Group in June 2021. Hong Yuan Holding Group was incorporated in 2001 and is based in Zhengzhou, China.
Full company profileHong Yuan Holding Group financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hong Yuan Holding Group annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 20.3M | 894K | 2.13M | - | 0.00 | 0.00 | 0.00 | 0.00 | 246K | 838K | 152K |
| Gross Profit | 2.03M | -81.0K | 252K | - | - | - | - | 0.00 | 92.9K | 540K | 86.9K |
| Operating Income | -12.4M | -19.4M | -4.39M | -24.4K | -18.9K | -46.3K | -58.3K | -39.7K | -96.3K | 176K | -380K |
| EBITDA | -11.5M | -21.3M | -5.02M | 216.00 | -18.9K | -46.3K | -58.3K | -38.3K | -94.9K | 178K | -376K |
| Net Income | -14.0M | -30.2M | -10.1M | -24.2K | -16.4K | -46.3K | -58.3K | -39.7K | -98.8K | 158K | -378K |
| EPS | -44 | -116 | -48 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 36.3M | 16.2M | - | 30.1K | 0.00 | 0.00 | 0.00 | 19.2K | 223K | 611K | 633K |
| Total Liabilities | 26.6M | 26.2M | - | 4.29K | 6.90K | 53.2K | 112K | 151K | 391K | 592K | 779K |
| Shareholders' Equity | 9.69M | -10.0M | - | 25.8K | -6.90K | -53.2K | -112K | -151K | -231K | -62.7K | -229K |
| Cash & Short-term Investments | 3.94M | 183K | - | - | - | - | - | 5.98K | 38.5K | 16.7K | 13.4K |
| Total Debt | 22.0M | 18.1M | - | 4.29K | 6.30K | 53.2K | 110K | - | - | 9.99K | 4.46K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -24.8M | -5.45M | - | -24.4K | -18.3K | -46.9K | -56.5K | -39.7K | -89.6K | -28.4K | -22.6K |
| Capital Expenditure | 7.92M | 182K | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.2K |
| Free Cash Flow | -32.7M | -5.64M | - | -24.4K | -18.3K | -46.9K | -56.5K | -39.7K | -89.6K | -26.4K | -8.41K |
| Ratios | |||||||||||
| ROE | -144.4% | - | - | -93.6% | - | - | - | - | - | - | - |
| ROA | -38.6% | -186.4% | - | -80.3% | - | - | - | -207.0% | -44.4% | 25.9% | -59.8% |
| Net Profit Margin | -69.1% | -3,373.8% | -475.3% | - | - | - | - | - | -40.3% | 18.9% | -249.4% |
| Debt to Equity | 2.27x | - | - | 0.17x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hong Yuan Holding Group dividends
Hong Yuan Holding Group has not paid dividends in the last 9 fiscal years.
Last stock split: 1:50 on Feb 21, 2014.
Who owns Hong Yuan Holding Group
- Insiders 66.99%
- Institutions 0.00%
- Public & others 33.01%
- Shares outstanding 74.6M
- Free float 24.6M
Hong Yuan Holding Group company profile
- Company name
- Hong Yuan Holding Group
- Ticker
- HGYN.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Capital Markets
- Employees
- 10
- Fiscal year end
- December
- Address
- Building 1 No. 176, Zhengzhou, China, 610094
- Phone
- 86 19 3821 85278
- Website
- -
About Hong Yuan Holding Group
Hong Yuan Holding Group does not have significant operations. previously, the company was engaged in the development and commercialization of bio-based resins. The company was formerly known as Cereplast, Inc. and changed its name to Hong Yuan Holding Group in June 2021. Hong Yuan Holding Group was incorporated in 2001 and is based in Zhengzhou, China.
Hong Yuan Holding Group management
2- Mr. Xudong LiCEO, President, Secretary & Director · born 1963
- Ms. Yanli MaChief Financial Officer · born 1973